A panel of advisors from the Food and Drug Administration is set to meet Tuesday to consider whether to use modern Inc.’s COVID-19 vaccine should be expanded to include children between the ages of 6 and 17.
The advisory committee is expected to vote Tuesday afternoon whether the benefits of vaccination to children in this age group outweigh the risks. FDA will consider vote in making final decision whether to clear the vaccine For use in children 6 years of age and older.